AlphaStocks
4.7
Weak

MCKESSON CORP (MCK)

Health Care / Health Care Distributors

S&P 500

$751.42

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#648out of 1123 in Health Care

Is MCKESSON CORP a Good Investment in 2026?

MCKESSON CORP (MCK) scores 4.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates MCKESSON CORP as Attractive (5/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. MCKESSON CORP currently trades below its estimated fair value of $1001, suggesting potential upside. MCKESSON CORP ranks #648 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E19.6ROE-274.5Market Cap93B

Estimated Fair Value

$1,000.7925% below

Fair value above market price. EPS grew 49% year-over-year. P/E of 20x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

PEG 1.5 · Stalwart

Greenblatt

Neutral

Bottom half (rank 64%)

Frequently Asked Questions

Is MCKESSON CORP (MCK) a good investment?
Based on AlphaStocks' composite analysis, MCKESSON CORP (MCK) scores 4.7 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. EPS grew 49% year-over-year. P/E of 20x is moderate for this quality level.
What is MCKESSON CORP's Piotroski F-Score?
MCKESSON CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MCK overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $1001, MCK appears undervalued. The stock currently trades 25% below its estimated fair value. Fair value above market price. EPS grew 49% year-over-year. P/E of 20x is moderate for this quality level.
How does MCK compare to other Health Care stocks?
MCKESSON CORP ranks #648 out of 1123 stocks in the Health Care sector, placing it in the top 58% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about MCK?
AlphaStocks evaluates MCK using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 4.7/10.

Similar Stocks

BFAMPARRAZN

Compare MCK with

MCK vs BFAMMCK vs PARRMCK vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer